Award Timing Disclosure

12 Months Ended

Dec. 31, 2024

USD ($)

$ / shares

Award Timing Disclosures [Line Items]

Policies and practices related to the grant of certain equity awards

We do not have any formal policy that requires us to grant, or avoid granting, equity-based compensation to our executive officers at certain times.

Historically, at its February meeting, it has been the Compensation Committee’s long-standing practice to review the Company’s results for the previous fiscal year, review the Company’s financial plan and strategy for the upcoming fiscal year and, based on those reviews, approve the granting of equity awards for the upcoming fiscal year to our named executive officers. These equity awards are granted at the same time that equity awards are granted to all other employees who are eligible for such awards.

The dates for this meeting are generally set more than a year in advance on a fairly consistent cadence year over year. This meeting generally occurs after we have issued our earnings release announcing our fourth quarter and full year financial results for the prior fiscal year, and closer in time to the filing of our related Annual Report on Form

10-K,

which we generally do not believe includes additional material information beyond what we disclosed in our earnings release. As a result, the timing of our annual grants of equity awards, including stock options, occurs independent of the release of any material,

non-public

information, and we do not time the disclosure of such information for the purpose of affecting the value of equity-based compensation.

As disclosed in the table below, for the annual equity grants that were made at the beginning of fiscal year 2024, the grants occurred one day before we filed our Annual Report on Form

10-K

for the fiscal year ended December 31, 2023. However, because we issued our earnings release with our financial results for the fourth quarter and fiscal year ended December 31, 2023, on January 31, 2024, we considered the trading window to be open at the time these annual grants were made.


Name	Grant date		Number of securities underlying the award (#)		Exercise price of the award ($)			Grant date fair value of the award ($)		Percentage change in the closing market price of the securities underlying the award between the trading day ending immediately prior to the disclosure of material nonpublic information and the trading day beginning immediately following the disclosure of material nonpublic information

Marc N. Casper		2/21/2024		94,130		$	552.85		14,470,769		2.1	%

Stephen Williamson		2/21/2024		32,113		$	552.85		4,779,797		2.1	%

Michel Lagarde		2/21/2024		38,015		$	552.85		5,642,596		2.1	%

Gianluca Pettiti		2/21/2024		34,716		$	552.85		5,157,710		2.1	%

Frederick Lowery		2/21/2024		24,090		$	552.85		3,607,722		2.1	%

Award Timing MNPI Considered

true

Awards Close in Time to MNPI Disclosures, Table

As disclosed in the table below, for the annual equity grants that were made at the beginning of fiscal year 2024, the grants occurred one day before we filed our Annual Report on Form

10-K


Name	Grant date		Number of securities underlying the award (#)		Exercise price of the award ($)			Grant date fair value of the award ($)		Percentage change in the closing market price of the securities underlying the award between the trading day ending immediately prior to the disclosure of material nonpublic information and the trading day beginning immediately following the disclosure of material nonpublic information

Marc N. Casper		2/21/2024		94,130		$	552.85		14,470,769		2.1	%

Stephen Williamson		2/21/2024		32,113		$	552.85		4,779,797		2.1	%

Michel Lagarde		2/21/2024		38,015		$	552.85		5,642,596		2.1	%

Gianluca Pettiti		2/21/2024		34,716		$	552.85		5,157,710		2.1	%

Frederick Lowery		2/21/2024		24,090		$	552.85		3,607,722		2.1	%